Toggle navigation
About
Abstract
Editorial Board
Subscription & Newsletter
Contact
Issues
This issue
22-4
All issues
Download PDF
Download EPUB
Editor's Selection
This issue
22-4
Browse by topic
Browse by contributor
Dialogue & Opinion
Abstracts
Abstracts
Search
Classification List
Abstracted Journals
Index of Authors
News & Reports
Home
Abstracts
Index of Authors
Author #87343
advertisement
Verticchio Vercellin A
18
Showing records 1 to 18 |
Display all abstracts from
Verticchio Vercellin A
99068
Choroidal Thickness and Primary Open-Angle Glaucoma-A Narrative Review
Verticchio Vercellin A
Journal of clinical medicine
2022; 11:
98167
Vascular biomarkers from optical coherence tomography angiography and glaucoma: where do we stand in 2021?
Shin JD
Acta Ophthalmologica
2022; 100: e377-e385
98596
Disease progression pathways of wet AMD: opportunities for new target discovery
Wolf AT; Wolf AT
Expert Opinion on Therapeutic Targets
2022; 26: 5-12
98167
Vascular biomarkers from optical coherence tomography angiography and glaucoma: where do we stand in 2021?
Wolf AT
Acta Ophthalmologica
2022; 100: e377-e385
99068
Choroidal Thickness and Primary Open-Angle Glaucoma-A Narrative Review
Harris A
Journal of clinical medicine
2022; 11:
98596
Disease progression pathways of wet AMD: opportunities for new target discovery
Harris A
Expert Opinion on Therapeutic Targets
2022; 26: 5-12
98167
Vascular biomarkers from optical coherence tomography angiography and glaucoma: where do we stand in 2021?
Wolf AT
Acta Ophthalmologica
2022; 100: e377-e385
99068
Choroidal Thickness and Primary Open-Angle Glaucoma-A Narrative Review
Stoner AM
Journal of clinical medicine
2022; 11:
98596
Disease progression pathways of wet AMD: opportunities for new target discovery
Oddone F
Expert Opinion on Therapeutic Targets
2022; 26: 5-12
98167
Vascular biomarkers from optical coherence tomography angiography and glaucoma: where do we stand in 2021?
Harris A; Verticchio Vercellin A
Acta Ophthalmologica
2022; 100: e377-e385
98596
Disease progression pathways of wet AMD: opportunities for new target discovery
Siesky B
Expert Opinion on Therapeutic Targets
2022; 26: 5-12
99068
Choroidal Thickness and Primary Open-Angle Glaucoma-A Narrative Review
Oddone F
Journal of clinical medicine
2022; 11:
98596
Disease progression pathways of wet AMD: opportunities for new target discovery
Verticchio Vercellin A
Expert Opinion on Therapeutic Targets
2022; 26: 5-12
99068
Choroidal Thickness and Primary Open-Angle Glaucoma-A Narrative Review
Mendoza KA
Journal of clinical medicine
2022; 11:
98167
Vascular biomarkers from optical coherence tomography angiography and glaucoma: where do we stand in 2021?
Siesky B; Rowe LW; Rowe LW
Acta Ophthalmologica
2022; 100: e377-e385
98596
Disease progression pathways of wet AMD: opportunities for new target discovery
Ciulla TA
Expert Opinion on Therapeutic Targets
2022; 26: 5-12
99068
Choroidal Thickness and Primary Open-Angle Glaucoma-A Narrative Review
Siesky B
Journal of clinical medicine
2022; 11:
98167
Vascular biomarkers from optical coherence tomography angiography and glaucoma: where do we stand in 2021?
Packles M; Oddone F
Acta Ophthalmologica
2022; 100: e377-e385
Issue
22-4
Table of Contents
Editor's Selection
PDF
EPUB
Change Issue
26-1
25-4
25-3
25-2
25-1
24-4
24-3
24-1/2
23-4
23-3
23-2
23-1
22-4
22-3
22-2
22-1
21-4
21-3
21-2
21-1
20-4
20-3
20-2
20-1
19-4
19-3
19-2
19-1
18-4
18-3
18-2
18-1
17-4
17-3
17-2
17-1
16-4
16-3
16-2
16-1
15-4
15-3
15-2
15-1
14-4
14-3
14-2
14-1
13-4
13-3
13-2
13-1
12-4
12-3
12-2
12-1
11-4
11-3
11-2
11-1
10-4
10-3
10-2
10-1
9-4
9-3
9-2
9-1
8-4
8-3
8-2
8-1
7-3
7-2
7-1
6-3
6-2
6-1
5-3
5-2
5-1
4-3
4-2
4-1
3-3
3-2
3-1
2-3
2-2
2-1
1-3
1-2
1-1
advertisement
We would like to use Google Analytics to see which parts of the review are read. It is only used to count visits, never for advertising.
Privacy statement
Decline
Accept